Skip to main content
Signal8

Javadi Alireza

SEC insider (Form 3/4/5 filer). CIK 0002123843. Chief Technical Officer at Rani Therapeutics Holdings, Inc. (RANI). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 27, 2026. Located in SAN JOSE, CA.

Companies Javadi Alireza has filed insider reports for

  • Rani Therapeutics Holdings, Inc. (RANI): Officer, Chief Technical Officer
Javadi Alireza profile photo

Javadi Alireza

CIK: 0002123843

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (25.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Rani Therapeutics Holdings, Inc. logo
RANI

Rani Therapeutics Holdings, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Rani Therapeutics Holdings, Inc. logo
    RANI

    Rani Therapeutics Holdings, Inc.

    Sep 27, 2026
    Tax Payment
    Direct
    309 shares at avg. $0.76$234.593
  • Rani Therapeutics Holdings, Inc. logo
    RANI

    Rani Therapeutics Holdings, Inc.

    Jun 27, 2026
    Tax Payment
    Direct
    309 shares at avg. $0.74$228.66
  • Rani Therapeutics Holdings, Inc. logo
    RANI

    Rani Therapeutics Holdings, Inc.

    Jun 3, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    805.5K shares-
  • Rani Therapeutics Holdings, Inc. logo
    RANI

    Rani Therapeutics Holdings, Inc.

    Mar 27, 2026
    Sale
    Direct
    386 shares at avg. $0.78$301.08

1-4 of 4